BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Repligen Corporation 

41 Seyon Street, Building #1, Suite 100

Waltham  Massachusetts  02495  U.S.A.
Phone: 781-250-0111 Fax: 781-250-0115


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Repligen Corporation (RGEN) To Report Third Quarter 2014 Financial Results 10/23/2014 7:47:53 AM
Repligen Corporation (RGEN) To Host Investor & Analyst Event On October 16 10/13/2014 7:34:17 AM
Repligen Corporation (RGEN) Reports Second Quarter 2014 Financial Results 8/11/2014 7:42:05 AM
Repligen Corporation (RGEN) To Report Second Quarter 2014 Financial Results 7/28/2014 7:44:56 AM
Repligen Corporation (RGEN) Hires Jon K. Snodgres As Chief Financial Officer 7/15/2014 6:24:04 AM
Repligen Corporation (RGEN) Scoops Up Small New Jersey Firm Refine Technology For $24.5 Million Cash/Stock Deal 6/4/2014 7:22:35 AM
Tosoh Bioscience, Inc. Introduces OPUS® Pre-Packed Chromatography Columns From Repligen Corporation (RGEN) 3/3/2014 10:18:12 AM
Repligen Corporation (RGEN), Continuing Overhaul, Flips Rare Disease Drugs To BioMarin Pharmaceutical Inc. (BMRN) In Deal Worth $162 Million 1/21/2014 8:15:41 AM
Repligen Corporation (RGEN) Reports Third Quarter 2013 Financial Results 11/7/2013 9:38:29 AM
Repligen Corporation (RGEN) to Present at the 2013 Stephens Fall Investment Conference 11/6/2013 9:29:23 AM
12345678910...